ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
暂无分享，去创建一个
B. Haines | C. Quéva | L. Lerner | Peter Grzesik | M. Finer | S. Feau | Lingxin Kong | Jennifer S. Lee | P. Behera | J. Hewett | Judy Jacques | Michael S. Ball | A. Denslow | D. Wambua | Terry Farkaly | Melissa Hayes | E. M. Kennedy | Caitlin Goshert | Allison M. Colthart | Daniel M. Wambua | Melissa W. Hayes | Sonia Feau